Skip to main content

Clinical Hypnosis
vs
Hot Flash Pills

A side-by-side comparison of two menopause relief methods — efficacy, cost, how they work, and who shouldn't use them.

Side-by-side comparison

Method
Clinical Hypnosis

Clinical Hypnosis

A therapist-guided technique using focused attention and suggestion to reduce hot flash frequency and severity.

Hot Flash Pills

Hot Flash Pills

A daily prescription pill (neurokinin receptor antagonist) that blocks NK3 receptors in the brain to reduce hot flashes and night sweats.

Efficacy80% reduction in hot flash score

Around 80% reduction in hot flash score.

Recommended see details

Recommended by the Menopause Society for symptom relief.

Cost$100–$250 /per unit

Insurance: Varies

$0–$780 /monthly

Insurance: Usually

Duration5 weekly sessions (about 45 minutes each)Daily pill (ongoing)
ReversibilityReversibleReversible
STI ProtectionNoNo
How it works

Clinical hypnosis uses focused attention, relaxation, and suggestion to alter the perception and frequency of hot flashes. The exact mechanism is not fully understood but may involve modulation of autonomic nervous system activity.

Blocks neurokinin-3 (NK3) and/or neurokinin-1 (NK1) receptors in the hypothalamus to interrupt the temperature-regulation pathway that triggers hot flashes and night sweats.

PrescriptionOTC Therapist-delivered (no Rx)Required Prescription required
Available Products1 product2 products
Side effects
  • None reported in trials
  • Elevated liver enzymes (requires monitoring)
  • Abdominal pain
  • Diarrhea
  • Insomnia
  • Back pain
  • Hot flush
  • Headache
  • Somnolence, dizziness, and fatigue (more common with dual NK1/NK3 antagonists)
Who shouldn't use thisNone reported
  • Cirrhosis or severe liver disease (NK3 antagonists such as fezolinetant)
  • Severe renal impairment or end-stage renal disease (NK3 antagonists such as fezolinetant)
  • Concomitant use of CYP1A2 inhibitors such as fluvoxamine or ciprofloxacin (NK3 antagonists such as fezolinetant)
  • Pregnancy (dual NK1/NK3 antagonists such as elinzanetant)